Case report: CAR-T cell therapy-induced cardiac tamponade

CD19-specific chimeric antigen receptor T (CAR-T) cell therapy has recently been shown to improve the prognosis of refractory diffuse large B-cell lymphoma (DLBCL). However, CAR-T cells may induce numerous adverse events, in particular cytokine release syndrome (CRS) which is frequently associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarfati, Sacha, Norbert, Misa Eugène, Hérault, Antoine, Giry, Marion, Makké, Jade, Grall, Maximilien, Savouré, Arnaud, Camus, Vincent, Alani, Mustafa, Tamion, Fabienne, Latouche, Jean-Baptiste, Girault, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067676/
https://www.ncbi.nlm.nih.gov/pubmed/37020516
http://dx.doi.org/10.3389/fcvm.2023.1132503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067676/
https://www.ncbi.nlm.nih.gov/pubmed/37020516
http://dx.doi.org/10.3389/fcvm.2023.1132503

Ejemplares similares